TIVICAY 50 MG 30 F.C. TABS

Antiretroviral Integrase Inhibitor (Anti-HIV) Labeled Indications HIV-1 infection treatment: Treatment of HIV-1 infection in combination with other antiretroviral agents in adult and pediatric patients weighing at least 30 kg or in combination with rilpivirine in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA <50 copies per mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure or known substitutions associated with resistance to either antiretroviral agent.